Clariane SEXPAR:CLARI +0.33%59 Market Cap is €1,499 Mil as of Jul. 03, 2026. GuruFocus rates XPAR:CLARI with a GF Score™ of 59/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Clariane SE ranks better than 87.05% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Clariane SE's share price for the quarter that ended in Dec. 2025 was €3.934. Clariane SE's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 357 Mil. Therefore, Clariane SE's market cap for the quarter that ended in Dec. 2025 was €1,402 Mil.
Clariane SE's quarterly market cap
increased
from Dec. 2024 (€743 Mil) to Jun. 2025 (€1,854 Mil) but then
declined
from Jun. 2025 (€1,854 Mil) to Dec. 2025 (€1,402 Mil).
Clariane SE's annual market cap
increased
from Dec. 2023 (€256 Mil) to Dec. 2024 (€743 Mil) and
increased
from Dec. 2024 (€743 Mil) to Dec. 2025 (€1,402 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Clariane SE's Enterprise Value for Today is €8,772 Mil.
Clariane SE (XPAR:CLARI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Clariane SE Market Cap Related Terms
Clariane SE Market Cap Historical Data
* Premium members only.
The historical data trend for Clariane SE's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:CLARI vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, Clariane SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Market Cap distribution charts can be found below:
* The bar in red indicates where Clariane SE's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Clariane SE's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (XPAR:CLARI) has a Market Cap of €1,499 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Clariane SE and its competitors. According to the industry distribution chart, Clariane SE ranks #90 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 12.9%.
Is Clariane SE's Market Cap too high?
Clariane SE's current Market Cap is €1,499 Mil. Based on the distribution chart, Clariane SE ranks #90 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #90 out of 695 companies for Market Cap. This places Clariane SE in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 97.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 97.60, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 97.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current Market Cap is €1,499 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (XPAR:CLARI) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.20 — trading 68.5% above its estimated fair value. The current Market Cap is €1,499 Mil. Clariane SE's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Clariane SE (XPAR:CLARI), the current Market Cap is €1,499 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (XPAR:CLARI) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.20 is trading 68.5% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for XPAR:CLARI:
Market Cap: €1,499 Mil
GF Value™: €2.49 vs. price of €4.20 (68.5% above fair value)
No single metric tells the full story. See the XPAR:CLARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
59GF Score
Get the complete analysis for XPAR:CLARI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:CLARI has been successfully added to your 
